Also known as Trizivir, Epzicom, and Ziagen
Abacavir (ABC) i/ʌ.bæk.ʌ.vɪər/ is a nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. It is available under the trade name Ziagen (ViiV Healthcare) and in the combination formulations Trizivir (abacavir, zidovudine and lamivudine) and Kivexa/Epzicom (abacavir and lamivudine). It has been well tolerated: the main side effect is hypersensitivity, which can be severe, and in rare cases, fatal. Genetic testing can indicate whether an individual will be hypersensitive; over 90% of patients can safely take abacavir. However, in a separate study, the risk of heart attack increased by nearly 90%.Source: Wikipedia
Estimated Total Cost: $489.41 for an average of 28 days supply
Patients are most commonly prescribed abacavir to treat human immunodeficiency virus infection (hiv), viral hepatitis, kidney failure, and peripheral nerve disorder.
Patients taking abacavir most commonly experience side effects like nausea, fatigue, and allergy.